About A1c

What is A1C?

A1C test results are reported as a percentage. A higher percentage indicates higher blood glucose levels in the past 2 to 3 months.
The A1C blood test is used to diagnose diabetes, plan your diabetes treatment, and monitor how well your treatment is working over time. (source)
A normal A1C level is below 5.7%, a level of 5.7% to 6.4% indicates prediabetes, and a level of 6.5% or more indicates diabetes. (source)

The higher the levels, the greater your risk of developing diabetes complications.

The ADA recommends that the goal for most adults with diabetes is an A1C level of less than 7%. However, there’s no one-size-fits-all target. The individual goal will depend on many things, such as your age and other medical conditions. Consult your doctor to set your own individual A1C goal. (source,source)

Unlike the glucose test, the A1C test does not require fasting before having blood drawn.

The OBM rapid A1c test allows a 5-minute A1C test at home using a fingerstick blood sample, offering laboratory-level accuracy.

Blogs

Read our most recent insights for people with diabetes and healthcare professionals.

Orange Biomed’s Journey in Diabetes Tech: Innovations Unveiled

Introduction The Diabetes Technology Meeting 2024 was a pivotal event for Orange Biomed, where industry leaders, researchers, and innovators converged to share insights and advancements in diabetes care. This year’s

Innovations in A1C Testing: What to Expect at the Diabetes Technology Meeting 2024

Introduction: Setting the Stage The Diabetes Technology Meeting 2024 is one of the most anticipated events in diabetes care, bringing together researchers, healthcare professionals, and innovators to showcase the latest

Health Inequity in Communities of Color: Why Education and Early Testing Are Life-Saving

Health inequity has long been an issue in the U.S. among communities of color. The effects of this widespread and persistent issue are devastating, resulting in higher prevalence and death

ADA 2023 Recap – New Method of A1c Testing for Better Diabetes Management and Diagnosis and More

The 83rd ADA 2023 Scientific Sessions occurred from June 23 – 26th in San Diego, California this year. Many industry leaders and innovators attended this year’s conference to address the

The AADA Is Leading the Fight Against Diabetes and Health Inequity

Health problems in the U.S. disproportionately impact Black Americans due to gaps in health care, socioeconomic inequalities, and systemic racism. As a result, organizations such as the African American Diabetes

Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings

Minority Patient Groups at Higher Risk of Developing Diabetes and Receiving Inaccurate A1c Readings The United States is home to many cultural and ethnic diversity. With this comes recognition of

Diabetes Technology Meeting

October 15-17, 2024

Explore groundbreaking advancements in diabetes care at the Diabetes Technology Meeting 2024, held in Burlingame, California.